electroCore宣布首名患者加入Gammacore™非侵入性迷走神经刺激治疗创伤后应激障碍研究者发起研究

美股速递04-07

生物电医学领域创新企业electroCore宣布，其Gammacore™非侵入性迷走神经刺激装置针对创伤后应激障碍的研究者发起临床试验已完成首例患者入组。这项由研究者主导的探索性研究旨在评估该非药物神经调节疗法对创伤后应激障碍患者的潜在疗效，标志着公司在拓展神经系统疾病治疗边界方面取得新进展。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1180234035?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-07 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180234035","market":"us","top_or_hot":-1,"title":"electroCore宣布首名患者加入Gammacore™非侵入性迷走神经刺激治疗创伤后应激障碍研究者发起研究","media":"美股速递","content":"<p>生物电医学领域创新企业electroCore宣布，其Gammacore™非侵入性迷走神经刺激装置针对创伤后应激障碍的研究者发起临床试验已完成首例患者入组。这项由研究者主导的探索性研究旨在评估该非药物神经调节疗法对创伤后应激障碍患者的潜在疗效，标志着公司在拓展神经系统疾病治疗边界方面取得新进展。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>electroCore宣布首名患者加入Gammacore™非侵入性迷走神经刺激治疗创伤后应激障碍研究者发起研究</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nelectroCore宣布首名患者加入Gammacore™非侵入性迷走神经刺激治疗创伤后应激障碍研究者发起研究\n</h2>\n\n<h4 class=\"meta\">\n\n2026-04-07 20:01 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>生物电医学领域创新企业electroCore宣布，其Gammacore™非侵入性迷走神经刺激装置针对创伤后应激障碍的研究者发起临床试验已完成首例患者入组。这项由研究者主导的探索性研究旨在评估该非药物神经调节疗法对创伤后应激障碍患者的潜在疗效，标志着公司在拓展神经系统疾病治疗边界方面取得新进展。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"","article_id":"1180234035","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180234035","pubTimestamp":1775563281,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"生物电医学领域创新企业electroCore宣布，其Gammacore™非侵入性迷走神经刺激装置针对创伤后应激障碍的研究者发起临床试验已完成首例患者入组。这项由研究者主导的探索性研究旨在评估该非药物神经调节疗法对创伤后应激障碍患者的潜在疗效，标志着公司在拓展神经系统疾病治疗边界方面取得新进展。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4082":"医疗保健设备","ECOR":"Electrocore LLC"},"translate_title":"electroCore Announces First Patient to Join Gammacore ™ Non-invasive vagus nerve stimulation for post-traumatic stress disorder Investigator-sponsored study","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ECOR":1},"content_text":"生物电医学领域创新企业electroCore宣布，其Gammacore™非侵入性迷走神经刺激装置针对创伤后应激障碍的研究者发起临床试验已完成首例患者入组。这项由研究者主导的探索性研究旨在评估该非药物神经调节疗法对创伤后应激障碍患者的潜在疗效，标志着公司在拓展神经系统疾病治疗边界方面取得新进展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180234035","isCrawlerRequest":true}